Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for surgical complications in lung cancer
NCT02856581Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in nicotine dependence, sponsored by Cancer and Leukemia Group B. Started Sep 2017; status: terminated.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02856581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856581.